Cardiac Resynchronization Therapy Reduces Metaboreflex Contribution to the Ventilatory Response in Heart Failure Population

Table 1

Baseline characteristics. Values are given as means ± S.E.M. BNP, brain natriuretic peptid; BP, blood pressure; EF, ejection fraction; LV, left ventricle; QOL: quality of life; TDV, tele-diastolic volume; TSV, tele-systolic volume.

	Patients
N	10
Age	62±9
Sex: male/female	9/1
Weight (kg)	79±16
Systolic BP (mmHg)	114±16
Heart rate (/min)	69±11
NYHA status	2.4±0.5
Etiology	Ischemia 𝑛=4
	Idiopathic 𝑛=5
	Valvular 𝑛=1
QRS (ms)	147±27
LV EF (%)	27±4
LV TSV (mL)	142±58
LV TDV (mL)	205±68
6-minute walking test (meters)	460±84
QOL score (Minnesota)	24±14
Creatinine (micromole/L)	93±13
BNP (pg/mL)	371±182
Medications
Beta blockers	9
ACE inhibitors	8